SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-22-226465
Filing Date
2022-08-22
Accepted
2022-08-22 16:15:01
Documents
1
Group Members
VERSANT VENTURES VI GP, L.P.VERSANT VENTURES VI GP-GP, LLCVERSANT VENTURES VII GP, L.P.VERSANT VENTURES VII GP-GP, LLCVERSANT VOYAGEURS I GP COVERSANT VOYAGEURS I GP, L.P.VERSANT VOYAGEURS I PARALLEL, L.P.VERSANT VOYAGEURS I, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d387632dsc13da.htm SC 13D/A 166488
  Complete submission text file 0001193125-22-226465.txt   168544
Mailing Address 400 FAIRVIEW AVENUE NORTH, SUITE 900 SEATTLE WA 98109
Business Address 400 FAIRVIEW AVENUE NORTH, SUITE 900 SEATTLE WA 98109 206-485-7051
CHINOOK THERAPEUTICS, INC. (Subject) CIK: 0001435049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88812 | Film No.: 221183901
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE SANSOME STREET, SUITE 3630 SAN FRANCISCO CA 94104
Business Address ONE SANSOME STREET, SUITE 3630 SAN FRANCISCO CA 94104 415-801-8100
Versant Venture Capital VII, L.P. (Filed by) CIK: 0001750266 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A